Related references
Note: Only part of the references are listed.
Article
Oncology
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: A central European cooperative oncology group international, multicenter, prospective, randomized phase III trial
C Zielinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Article
Oncology
Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000
SH Giordano et al.
CANCER (2004)
Article
Oncology
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices
GH Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)